These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27230788)

  • 1. Donor CD47 controls T cell alloresponses and is required for tolerance induction following hepatocyte allotransplantation.
    Zhang M; Wang H; Tan S; Navarro-Alvarez N; Zheng Y; Yang YG
    Sci Rep; 2016 May; 6():26839. PubMed ID: 27230788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation.
    Navarro-Alvarez N; Yang YG
    Cell Transplant; 2014 Mar; 23(3):345-54. PubMed ID: 23394628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of regulatory T cells in CD47/donor-specific transfusion-induced immune tolerance in skin-heart transplantation mice.
    Hu Y; Zhou H; Gao B; Wang G; Wang Y
    Transpl Infect Dis; 2019 Feb; 21(1):e13012. PubMed ID: 30320937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD47 is required for suppression of allograft rejection by donor-specific transfusion.
    Wang H; Wu X; Wang Y; Oldenborg PA; Yang YG
    J Immunol; 2010 Apr; 184(7):3401-7. PubMed ID: 20208011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of donor CD47 protects against vascularized allograft rejection in mice.
    Chen M; Wang Y; Wang H; Sun L; Fu Y; Yang YG
    Xenotransplantation; 2019 Mar; 26(2):e12459. PubMed ID: 30136356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid dendritic cell activation and resistance to allotolerance induction in anti-CD154-treated mice receiving CD47-deficient donor-specific transfusion.
    Wang Y; Wang H; Bronson R; Fu Y; Yang YG
    Cell Transplant; 2014 Mar; 23(3):355-63. PubMed ID: 23295133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells.
    Pengam S; Durand J; Usal C; Gauttier V; Dilek N; Martinet B; Daguin V; Mary C; Thepenier V; Teppaz G; Renaudin K; Blancho G; Vanhove B; Poirier N
    Am J Transplant; 2019 Dec; 19(12):3263-3275. PubMed ID: 31207067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Survival of Pig Skin on Baboons After Administration of Pig Cells Expressing Human CD47.
    Tena AA; Sachs DH; Mallard C; Yang YG; Tasaki M; Farkash E; Rosales IA; Colvin RB; Leonard DA; Hawley RJ
    Transplantation; 2017 Feb; 101(2):316-321. PubMed ID: 27232934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.
    Miyairi S; Hirai T; Ishii R; Okumi M; Nunoda S; Yamazaki K; Ishii Y; Tanabe K
    Eur J Immunol; 2017 Apr; 47(4):734-742. PubMed ID: 28127757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
    Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
    Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.
    Shahzad KA; Wan X; Zhang L; Pei W; Zhang A; Younis M; Wang W; Shen C
    Drug Deliv; 2018 Nov; 25(1):703-715. PubMed ID: 29508634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 expression on T cell is a self-control negative regulator of type 1 immune response.
    Bouguermouh S; Van VQ; Martel J; Gautier P; Rubio M; Sarfati M
    J Immunol; 2008 Jun; 180(12):8073-82. PubMed ID: 18523271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
    Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
    J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.
    Bumgardner GL; Li J; Heininger M; Ferguson RM; Orosz CG
    Transplantation; 1998 Jan; 65(1):47-52. PubMed ID: 9448143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene.
    Li Z; Yang N; Zhou L; Gu P; Wang H; Zhou Y; Zhou P; Lu L; Chou KY
    Immunology; 2016 Mar; 147(3):355-66. PubMed ID: 26694804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
    Fu BM; He XS; Yu S; Hu AB; Zhang J; Ma Y; Tam NL; Huang JF
    Cell Immunol; 2010; 261(1):69-76. PubMed ID: 20038461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.